About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

TRANSGENIC GROUP INC.(2342) Summary

2342
TSE Growth
TRANSGENIC GROUP INC.
177
JPY
+17
(+10.63%)
Apr 10, 3:30 pm JST
1.20
USD
Apr 10, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
PBR
0.53
Yield
ー%
Margin Trading Ratio
Stock Price
Apr 10, 2025
Opening Apr 10, 9:06 am
171 JPY 1.16 USD
Previous Close Apr 9
160 JPY 1.10 USD
High Apr 10, 11:07 am
193 JPY 1.31 USD
Low Apr 10, 9:17 am
163 JPY 1.10 USD
Volume
1,947,100
Trading Value
0.34B JPY 2.32M USD
VWAP
175.2 JPY 1.19 USD
Minimum Trading Value
17,700 JPY 120 USD
Market Cap
3.01B JPY 0.02B USD
Number of Trades
1,252
Liquidity & Number of Trades
As of Apr 10, 2025
Liquidity
Mid
1-Year Average
92
1-Year High Apr 25, 2024
1,950
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 4, 2025 0 642,800
Mar 28, 2025 0 651,800
Mar 21, 2025 0 607,100
Mar 14, 2025 0 604,500
Mar 7, 2025 0 577,400
Company Profile
TRANSGENIC GROUP INC. is a biotech venture supporting drug discovery research. The company specializes in genetic analysis using mice and is expanding through succession-based M&A.
Sector
Services
TRANSGENIC GROUP INC. operates two main business segments: drug discovery support and investment/consulting. In the drug discovery support segment, the company offers services such as genetically modified mouse production, antibody production, glycan analysis and synthesis, preclinical trials, and clinical trial outsourcing. The investment and consulting segment focuses on promoting new businesses through M&A and supporting business succession and revitalization. This segment includes various activities such as the sale of electrical products, import and sale of Western tableware, development and sale of information and communication equipment, import and sale of auxiliary materials for multi-layered glass and glass processing equipment, and import and sale of printer toners.